Immunological Hypersensitivities: Allergy and Autoimmunity

2023

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.1007/978-3-031-27133-5_23
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

In this chapter, we will discuss about different types of hypersensitivities of the immune system, which are either mediated primarily by IgEs and T H 2 cells (type I), IgGs and IgMs (type II), immune complexes (type III) and T cells (type IV). While type I hypersensitivity causes different forms of allergy, the basis for distinct autoimmune diseases are type II–IV hypersensitivities. The underlying mechanisms for all hypersensitivities, is the failure of mechanisms responsible for maintaining self-tolerance in B cells, T cells or both. We will outline the effector mechanisms, responsible for tissue injury and disease in the context of these hypersensitivities, which are based on genetic susceptibility and environmental triggers, such as infections. Organ-specific autoimmune diseases, such as T1D and MS are distinguished from those that are systemic, such as rheumatoid arthritis and SLE. We will summarize these principles in the equilibrium model of immunity.